Cspc Pharmaceutical Hits 6: month high on profit, dividend surge
BUZZ-CSPC Pharmaceutical hits 6-month high on profit, dividend surge ** Shares of CSPC Pharmaceutical Group 1093.HK jump 17.1% to HK$10.17, their highest level since February 25
** Stock on track for its biggest one-day pct gain since June 2012
** Second-biggest percentage gainer on the benchmark Hang Seng Index .HSI, which gains 1.1%
** Chinese pharmaceutical maker said H1 profit attributable jumped 139% y/y with total revenue up 40% y/y driven by finished drugs growth
** Co declares an interim dividend of HK$0.18 per share, up 28.6% from HK$0.14 each a year ago
** YTD, stock up 16.9%, Hang Seng Biotech Index .HSBIO up 15.9%
(Reporting by Donny Kwok)
Recent news on CSPC PHARMACEUTICAL
See all newsBrief: CSPC Pharmaceutical Posts CSPC Innovation Pharmaceutical 9M Net Profit Attributable RMB 1.21 Billion
Brief: CSPC Pharmaceutical Publishes Updated Phase III OS Results For Anbenitamab In Her2-Positive Advanced Gastric Cancer
Brief: CSPC Pharmaceutical Says Batoclimab Injection (Enlida) Obtains Drug Registration Certificate From NMPA
Brief: CSPC Pharmaceutical Initiates Phase III Trial Of SYS6043 For Triple-Negative Breast Cancer In China
Factbox: Pharma sector doubles down on AI to slash costs, timelines